Biologically Active Small Molecules, 5 mg, 50-76-0
Benchmark BenchPress 2024 - Promos & Lab Favorites
Shakers, Incubators, Centrifuges, Balances, Rotators,
Vortexers, Dry Baths, Rockers and MORE!
Download the promotional brochure below learn more.
Benchmark BenchPress 2024 Promotional Brochure
Offers expire July 31, 2024
-
Actinomycin
LKT LabsActinomycin D is a polypeptide antibiotic produced from Streptomyces; it exhibits anticancer chemotherapeutic activity but does not display antibacterial benefit. Actinomycin D is clinically used to treat various cancers and is one component of the VAC chemotherapy regimen. Actinomycin D binds DNA,…
-
Actinomycin D
Cayman ChemicalA cyclic polypeptide-containing anticancer antibiotic that binds to DNA and blocks transcription by interfering with RNA synthesis; ~10 nM promotes cell death in a variety of tumors.